The antiviral formula offers a synergistic combination of five clinically validated herbal extracts, standardized to ensure optimal potency and efficacy. ECHINAMIDE is a well-established formulation of organically grown Echinacea purpurea, triple-standardized for key constituents (alkylamides, cichoric acid, and polysaccharides) that have been shown to enhance immune function and significantly reduce cold symptoms in randomized clinical trials. ECHINAMIDE stimulates the nonspecific immune system, increasing the total number of leukocytes, neutrophils, monocytes, and natural killer cells. Its alkylamides have anti-inflammatory and immunomodulatory effects, in part by binding to cannabinoid receptors on immune cells. The polysaccharides and polyphenols induce cell-mediated immunity and help stabilize secretory IgA levels. Although meta-analyses generally support the use of echinacea as an antiviral, standardization of its key components is essential to ensure clinical benefit.
This powerful antiviral formula also contains extracts of lomatium and reishi mushroom, long-used antiviral herbs. Reishi contains triterpenoids that inhibit both viral entry into the cell and viral replication, and lomatium has in vitro inhibitory effects on rotavirus and blocks the production of CXCL10, a key signaling molecule for influenza and other viral infections. Extracts of echinacea, licorice, and astragalus have been shown to increase the production of CD25 and work synergistically to induce greater expression of CD69, two indicators of immune cell activation and regulation. The broad antiviral and adaptogenic properties of these herbs support their combined use to optimize immune function and support upper respiratory health.